Undertaking w.r.t Non-applicablity of Related Party Transaction under Reg 23 of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has submitted an undertaking to BSE stating that the Related Party Transaction (RPT) requirements under Regulation 23 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015 do not apply to the company for the half year ended September 30, 2025. The company explains that it is listed on the SME platform of BSE and does not cross the specified threshold limits, making it exempt under Regulation 15 of the SEBI LODR Regulations. The letter is signed by Jagdish Umakant Nayak, Chairman and Managing Director. This is a routine compliance filing confirming exemption rather than a disclosure of any transactions.
This is a procedural compliance filing with no material impact on shareholders or stock price. Investors should note the company qualifies as an SME-listed entity exempt from RPT disclosure norms, which is a regulatory status rather than a corporate action.